A Letter From Our CEO
As we reflect on the past year, I am proud to share that VIC Tech has once again demonstrated resilience and ingenuity in a challenging venture capital landscape. Despite continued headwinds, 2024 was marked by...
As we reflect on the past year, I am proud to share that VIC Tech has once again demonstrated resilience and ingenuity in a challenging venture capital landscape. Despite continued headwinds, 2024 was marked by...
The use of artificial intelligence (AI) and machine learning (ML) in healthcare and related industries has increased dramatically in recent years. In the world of healthcare startups, founders and investors are faced...
Dallas, TX (November 8th, 2024) - Solenic Medical Inc. won the Industry Innovation Award at the 2024 annual meeting of the American Association of Hip and Knee Surgeons (AAHKS) held in Dallas TX, from November 8th to...
The VIC Fellows Program provides an opportunity for individuals with relevant expertise and interest to learn how to identify and evaluate promising innovations from global sources. We are pleased to highlight the...
Enhance Diagnostics has been awarded a $25,000 prize from the American Academy of Pediatrics (AAP) Section on Advances in Therapeutics and Technology (SOATT) and the Southwest National Pediatric Device Innovation...
Fayetteville, AR—VIC Tech, a leading builder of high-impact, innovative life science companies, announces the formation of i-Seq Biotechnology, a portfolio company focused on advancing novel broad-spectrum vaccines and...
Can you share a bit about your career journey and what led you to your current roles at CU Innovations? How have your previous experiences shaped your approach to innovation and investment? My career journey has been a...
VIC Tech is pleased to announce the expansion of its Scientific Advisory Board (SAB) and Medical Advisory Board (MAB) with the addition of two esteemed experts. Dr. Alexandra H. Antonioli, MD, PhD, joins the MAB, and...
As has been thoroughly discussed by this author and others, the so-called “valley of death” is a critical barrier for the advancement of life science (therapeutic, vaccine, medical device, diagnostic and related)...
Aurora, CO - Neurexis Therapeutics, a leading biopharmaceutical company focused on developing neuroprotective interventions, has been awarded a prestigious $3 million Phase II Small Business Innovation Research (SBIR)...
FEATURED RESOURCES
Technology Solutions For A Better World
Our mission is to form and grow life science and emerging technology companies that shape the future by bringing innovative discoveries from research labs to commercial deployment.
Subscribe to the VIC newsletter.